MiNK Therapeutics, Inc.(NASDAQ:INKT) 
MiNK Therapeutics, Inc. operates as a clinical stage biopharmaceutical company engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T cell therapies to treat cancer and other immune-mediated diseases. The company was founded in 2017 and ...
Website: http://minktherapeutics.com
Founded: 2017
CEO: Jennifer Buell
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-01
P
O 9.67
H 9.67
L 8.54
C 9.22
V 5,890
10EMA 9.22
20EMA 9.22
60EMA 9.22
120EMA 9.22
250EMA 9.22